Emerging Company Profile: Chinese siRNA Specialist Sirius All In On Cardiovascular Disease

Potential Once-Yearly Regimen

 
• By Dexter Jie Yan
cardiovascular diseases
Chinese siRNA therapy developer aims at cardiovascular diseases with potential once-yearly regimen • Source: Shutterstock

More from China

More from Focus On Asia